Hypoxia modulation of peroxisome proliferator-activated receptors (PPARs) in human glioblastoma stem cells. Implications for therapy

Journal of Cellular Biochemistry

Volumn 113, Issue 11, 2012, Pages 3342-3352

  Galzio, Renato ^a   Cristiano, Loredana ^a   Fidoamore, Alessia ^a   Cifone, Maria Grazia ^a   Benedetti, Elisabetta ^a   Cinque, Benedetta ^a   Menghini, Paola ^a   Raysi Dehcordi, Sohelia ^a   Ippoliti, Rodolfo ^a   Giordano, Antonio ^a,b,c   Cimini, Annamaria ^a,c  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c TEMPLE UNIVERSITY   (United States)

Author keywords

GLIOBLASTOMA STEM CELLS; HYPOXIA; PPARs

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ARTICLE; CANCER RECURRENCE; CANCER STEM CELL; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GLIOBLASTOMA; HYPOXIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

BIOLOGICAL MARKERS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLESTEROL; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MICROSCOPY, FLUORESCENCE; NEOPLASTIC STEM CELLS; OXYGEN; PPAR ALPHA; PPAR GAMMA; PPAR-BETA; SIGNAL TRANSDUCTION;

EID: 84866521955     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24210     Document Type: Article

References (55)

1. Amberger-Murphy V,. 2009. Hypoxia helps glioma to fight therapy. Curr Cancer Drug Targets 9: 381-390.
2. Bar EE,. 2011. Glioblastoma, cancer stem cells and hypoxia. Brain Pathol 21: 119-129.
3. Bar EE, Lin A, Mahairaki V, Matsui W, Eberhart CG,. 2010. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am J Pathol 177: 1491-1502.
4. Benedetti E, Galzio R, Cinque B, Biordi L, D'Amico MA, D'Angelo B, Laurenti G, Ricci A, Festuccia C, Cifone MG, Lombardi D, Cimini A,. 2008. Biomolecular characterization of human glioblastoma cells in primary cultures: Differentiating and antiangiogenic effects of natural and synthetic PPARgamma agonists. J Cell Physiol 217: 93-102.
5. Benedetti E, Galzio R, D'Angelo B, Cerà MP, Cimini A,. 2010a. PPARs in human neuroepithelial tumors: PPAR ligands as anticancer therapies for the most common human neuroepithelial tumors. PPAR Res 2010: 427401.
6. Benedetti E, Galzio R, Laurenti G, D'Angelo B, Melchiorre E, Cifone MG, Fanelli F, Muzi P, Coletti G, Alecci M, Sotgiu A, Cerà MP, Cimini A,. 2010b. Lipid metabolism impairment in human gliomas: expression of peroxisomal proteins in human gliomas at different grades of malignancy. Int J Immunopathol Pharmacol 23: 235-246.
7. Berger J, Moller DE,. 2002. The mechanisms of action of PPARs. Ann Rev Med 53: 409-435.
8. Bligh EG, Dyer WJ,. 1959. A rapid method for total lipid extraction and purification. Can J Biochem Physiol 37: 911-917.
9. Bylund M, Andersson E, Novitch BG, Muhr J,. 2003. Vertebrate neurogenesis is counteracted by Sox1-3 activity. Nat Neurosci 6: 1162-1168.
10. Chan KK, Oza AM, Siu LL,. 2003. The statins as anticancer agents. Clin Cancer Res 9: 10-19.
11. Cimini A, Cerà MP,. 2008. Emerging roles of peroxisome proliferator-activated receptors (PPARs) in the regulation of neural stem cells proliferation and differentiation. Stem Cell Rev 4: 293-303.
12. Cimini A, Ippoliti R,. 2011. Innovative therapies against human glioblastoma multiforme. ISRN Oncol 2011: 787490.
13. Cimini A, Cristiano L, Benedetti E, D'Angelo B, Cerà MP,. 2007. PPARs expression in adult mouse neural stem cells: Modulation of PPARs during astroglial differentiaton of NSC. PPAR Res 2007: 48242.
14. D'Angelo B, Benedetti E, Di Loreto S, Laurenti G, Cerà MP, Cimini A,. 2011. Signal transduction pathways involved in PPARÃ-induced neuronal differentiation 1. J Cell Physiol 226: 2170-2180.
15. Da Silva CA, Heilbock C, Kassel O, Frossard N,. 2003. Transcription of stem cell factor (SCF) is potentiated by glucocorticoids and interleukin-1beta through concerted regulation of a GRE-like and an NF-kappaB response element. FASEB J 17: 2334-2336.
16. Di Benedetto R, Denti MA, Salvati S, Sanchez M, Attorri L, David G, Di Biase A,. 2008. RNAi-mediated silencing of ABCD3 gene expression in rat C6 glial cells: A model system to study PMP70 function. Neurochem Int 52: 1106-1113.
17. Di Loreto S, Corvetti L, Maccarone R, Piancatelli D, Adorno D,. 2000. Interleukin 1-beta modulates the effects of hypoxia in neuronal culture. J Neuroimmunol 106: 32-42.
18. Doherty GH,. 2007. Developmental switch in the effects of TNFalpha on ventral midbrain dopaminergic neurons. Neurosci Res 57: 296-305.
19. Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W,. 1992. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68: 879-887.
20. Edvardsson U, Ljungberg A, Linden D, William-Olsson L, Peilot-Sjogren H, Ahnmark A, Oscarsson J,. 2006. PPAR-alpha activation increases triglycerides mass and adipose differentiation-related protein in hepatocytes. J Lipid Res 47: 329-340.
21. Escher P, Wahli W,. 2000. Peroxisome proliferator-activated receptors: Insight into multiple cellular functions. Mutat Res 448: 121-138.
22. 2 tensions and the prevention of differentiation of hES cells. Proc Natl Acad Sci USA 102: 4783-4788.
23. Feige JN, Gelman L, Michalik L, Desvergne B, Wahli W,. 2006. From molecular action to physiological outputs: Peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Progr Lipid Res 45: 120-159.
24. Garza JC, Guo M, Zhang W, Lu XY,. 2008. Leptin increases adult hippocampal neurogenesis in vivo and in vitro. J Biol Chem 283: 18238-18247.
25. Gearing KL, Gottlicher M, Teboul M, Widmark E, Gustafsson JA,. 1993. Interaction of the peroxisome-proliferatoractivated receptor and retinoid X receptor. Proc Natl Acad Sci USA 90: 1440-1444.
26. Goldstein JL, Brown MS,. 1990. Regulation of the mevalonate pathway. Nature 343: 425-430.
27. Guillemot F,. 2007. Cell fate specification in the mammalian telencephalon. Prog Neurobiol 83: 37-52.
28. Gupta S, Takebe N, Lorusso P,. 2010. Targeting the Hedgehog pathway in cancer. Ther Adv Med Oncol 2: 237-250.
29. Issemann I, Green S,. 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347: 645-650.
30. Jensen RL,. 2009. Brain tumor hypoxia: Tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target. J Neurooncol 92: 317-335.
31. Jung Y, Song S, Choi C,. 2008. Peroxisome proliferator activated receptor γ agonists suppress TNFα-induced ICAM-1 expression by endothelial cells in a manner potentially dependent on inhibition of reactive oxygen species. Immunol Lett 117: 63-69.
32. Keller H, Dreyer C, Medin J, Mahfoudi A, Ozato K, Wahli W,. 1993. Fatty acids and retinoids control lipid metabolismthrough activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci USA 90: 2160-2164.
33. Krey G, Braissant O, L'Horset F, Kalkhoven E, Perroud M, Parker MG,. 1997. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 11: 779-791.
34. Laurenti G, Benedetti E, D'Angelo B, Cristiano L, Cinque B, Raysi S, Alecci M, Cerà MP, Cifone MG, Galzio R, Giordano A,. 2011. Cimini A Hypoxia induces peroxisome proliferator-activated receptor α (PPARα) and lipid metabolism peroxisomal enzymes in human glioblastoma cells. J Cell Biochem 112: 3891-3901.
35. Livak KJ, Schmittgen TD,. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
36. McCord AM, Jamal M, Shankavaram UT, Lang FF, Camphausen K, Tofilon PJ,. 2009. Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro. Mol Cancer Res 7: 489-497.
37. Medes G, Thomas A, Weinhouse S,. 1953. Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res 13: 27-29.
38. Morales-Garcia JA, Luna-Medina R, Alfaro-Cervello C, Cortes-Canteli M, Santos A, Garcia-Verdugo JM, Perez-Castillo A,. 2011. Peroxisome proliferator-activated receptor γ ligands regulate neural stem cell proliferation and differentiation in vitro and in vivo. Glia 59: 293-307.
39. Nuclear Receptor Nomenclature Committee. 1999. A unified nomenclature system for the nuclear receptor superfamily. Cell 97: 161-163.
40. Opstad KS, Bell BA, Griffiths JR, Howe FA,. 2008. An investigation of human brain tumour lipids by high-resolution magic angle spinning 1H MRS and histological analysis. NMR Biomed 21: 677-685.
41. Panchision DM,. 2009. The role of oxygen in regulating neural stem cells in development and disease. J Cell Physiol 220: 562-568.
42. Pistollato F, Chen HL, Rood BR, Zhang HZ, D'Avella D, Denaro L, Gardiman M, te Kronnie G, Schwartz PH, Favaro E, Indraccolo S, Basso G, Panchision DM,. 2009. Hypoxia and HIF1alpha repress the differentiative effects of BMPs in high-grade glioma. Stem Cells 27: 7-17.
43. Sahlgren C, Gustafsson MV, Jin S, Poellinger L, Lendahl U,. 2008. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci USA 105: 6392-6397.
44. Sathornsumetee S, Cao Y, Marcello JE, Herndon JE II, McLendon RE, Desjardins A, Friedman HS, Dewhirst MW, Vredenburgh JJ, Rich JN,. 2008. Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan. J Clin Oncol 26: 271-278.
45. Smith PK, Krohn RI, Hermanson GT, et al. 1985. Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85.
46. Soeda A, Park M, Lee D, Mintz A, Androutsellis-Theotokis A, McKay RD, Engh J, Iwama T, Kunisada T, Kassam AB, Pollack IF, Park DM,. 2009. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 28: 3949-3959.
47. Stottmann RW, Turbe-Doan A, Tran P, Kratz LE, Moran JL, Kelley RI, Beier DR,. 2011. Cholesterol metabolism is required for intracellular hedgehog signal transduction in vivo. PLoS Genet 7: e1002224.
48. Sun L, Lee J, Fine HA,. 2004. Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury. J. Clin. Invest 113: 1364-1374.
49. Thérond PP,. 2012. Release and transportation of Hedgehog molecules. Curr Opin Cell Biol 24: 173-180.
50. Vaupel P, Mayer A,. 2007. Hypoxia in cancer: Significance and impact on clinical outcome. Cancer Metastasis Rev 26: 225-239.
51. Wang SH, Guo YJ, Yuan Y, Li L, Li FF, Ye KP, Huang Y,. 2011. PPARγ-mediated advanced glycation end products regulate neural stem cell proliferation but not neural differentiation through the BDNF-CREB pathway. Toxicol Lett 206: 339-346.
52. Wada K, Nakajima A, Katayama K, Kudo C, Shibuya A, Kubota N, Terauchi Y, Tachibana M, Miyoshi H, Kamisaki Y, Mayumi T, Kadowaki T, Blumberg RS,. 2006. Peroxisome proliferator-activated receptor γ-mediated regulation of neural stem cell proliferation and differentiation. J Biol Chem 81: 12673-12681.
53. Widera D, Holtkamp W, Entschladen F, Niggemann B, Zänker K, Kaltschmidt B, Kaltschmidt C,. 2004. MCP-1 induces migration of adult neural stem cells. Eur J Cell Biol 83: 381-387.
54. Wolfrum C, Borrmann CM, Borchers T, Spener F,. 2001. Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha- and gamma-mediated gene expression via liver fatty acid binding protein: A signaling path to the nucleus. Proc Natl Acad Sci USA 98: 2323-2328.
55. Yu SC, Ping YF, Yi L, Zhou ZH, Chen JH, Yao XH, Gao L, Wang JM, Bian XW,. 2008. Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Lett 265: 124-134.